Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pra Health (PRAH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,275,991
  • Shares Outstanding, K 64,975
  • Annual Sales, $ 2,259 M
  • Annual Income, $ 86,930 K
  • 36-Month Beta 1.14
  • Price/Sales 2.65
  • Price/Cash Flow 24.21
  • Price/Book 7.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.18
  • Number of Estimates 6
  • High Estimate 1.20
  • Low Estimate 1.17
  • Prior Year 1.04
  • Growth Rate Est. (year over year) +13.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.05 +13.06%
on 01/22/19
114.81 -2.46%
on 02/19/19
+10.34 (+10.17%)
since 01/18/19
3-Month
82.12 +36.37%
on 01/04/19
121.98 -8.19%
on 12/03/18
+13.76 (+14.01%)
since 11/21/18
52-Week
79.20 +41.40%
on 05/17/18
121.98 -8.19%
on 12/03/18
+23.00 (+25.85%)
since 02/21/18

Most Recent Stories

More News
PRA Health Sciences (PRAH) Reports Next Week: Wall Street Expects Earnings Growth

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRAH : 111.99 (-1.68%)
Pra Health Scien Has Returned 18.9% Since SmarTrend Recommendation (PRAH)

SmarTrend identified an Uptrend for Pra Health Scien (NASDAQ:PRAH) on January 8th, 2019 at $93.33. In approximately 1 month, Pra Health Scien has returned 18.92% as of today's recent price of $110.98....

PRAH : 111.99 (-1.68%)
Watch for Pra Health Scien to Potentially Pullback After Gaining 1.68% Yesterday

Pra Health Scien (NASDAQ:PRAH) traded in a range yesterday that spanned from a low of $107.40 to a high of $108.95. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high...

PRAH : 111.99 (-1.68%)
Analysis: Positioning to Benefit within Conagra Brands, National Retail Properties, PRA Health Sciences, Westinghouse Air Brake Technologies, YRC Worldwide, and Infinity Pharmaceuticals -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Conagra Brands Inc. (NYSE:CAG),...

YRCW : 8.18 (-0.24%)
CAG : 24.07 (+0.17%)
WAB : 73.58 (-2.00%)
INFI : 1.70 (+24.09%)
PRAH : 111.99 (-1.68%)
NNN : 52.54 (+1.94%)
Zosano Appoints Linda Grais M.D., J.D. to Board of Directors

Zosano Pharma Corporation (NASDAQ:ZSAN) ("Zosano" or the "Company"), a clinical-stage biopharmaceutical company, today announced the appointment of Linda Grais, M.D., J.D. to its board of directors.

LLY : 122.72 (+0.05%)
ABIO : 0.47 (-6.86%)
ZSAN : 6.00 (+171.49%)
PRAH : 111.99 (-1.68%)
OCRX : 1.79 (+1.13%)
TVTY vs. PRAH: Which Stock Is the Better Value Option?

TVTY vs. PRAH: Which Stock Is the Better Value Option?

TVTY : 22.47 (+0.40%)
PRAH : 111.99 (-1.68%)
TVTY or PRAH: Which Is the Better Value Stock Right Now?

TVTY vs. PRAH: Which Stock Is the Better Value Option?

TVTY : 22.47 (+0.40%)
PRAH : 111.99 (-1.68%)
Symphony Health Announces Availability of 340B Drug Discount Program Data

Symphony Health, a PRA Health Sciences company and a leading provider of data, cloud-based analytics and consulting solutions to life science companies and healthcare organizations, today announces the...

PRAH : 111.99 (-1.68%)
Express Scripts (ESRX) Soars to 52-Week High, Time to Cash Out?

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AMN : 53.13 (-0.78%)
ESRX : 92.33 (-3.62%)
BEAT : 73.34 (-2.71%)
PRAH : 111.99 (-1.68%)
Express Scripts (ESRX) Hits 52-Week High, Can the Run Continue?

Express Scripts (ESRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AMN : 53.13 (-0.78%)
ESRX : 92.33 (-3.62%)
BEAT : 73.34 (-2.71%)
PRAH : 111.99 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade PRAH with:

Business Summary

PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology...

See More

Key Turning Points

2nd Resistance Point 115.07
1st Resistance Point 113.53
Last Price 111.99
1st Support Level 111.10
2nd Support Level 110.21

See More

52-Week High 121.98
Last Price 111.99
Fibonacci 61.8% 105.64
Fibonacci 50% 100.59
Fibonacci 38.2% 95.54
52-Week Low 79.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar